Screener / SEC EDGAR /CIK 0001295947 /10-K filed May 14, 2026, compared with May 9, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Prestige Consumer Healthcare Inc. PBH

Compare with peers Embed
Planned sales, announced before they happen

1 trading plan running, 8 Form 144 notices for $424K

10-Q, 10-K and Form 144

What PBH's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Sep 15, 2023 to Aug 27, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Jeffrey Zerillo
Senior Vice President Operations
Adopted 10b5-1 plan Jun 11, 2026 10-Q Aug 6, 2026
What the company wrote
Name and Position Date of Signature Effective Date Action Satisfies Affirmative Defense under Rule 10b5-1(c) Expiration Date Total Ordinary Shares to be Sold Jeffrey Zerillo June 11, 2026 October 1, 2026 Adoption X August 27, 2027 10,444 Senior Vice President Operations
Jeffrey Zerillo
Senior Vice President Operations
Adopted 10b5-1 plan Aug 26, 2025 10-Q Nov 6, 2025
What the company wrote
Name and Position Date Action Satisfies Affirmative Defense under Rule 10b5-1(c) Expiration Date Total Ordinary Shares to be Sold Jeffrey Zerillo August 26, 2025 Adoption X September 30, 2026 12,594 Senior Vice President Operations
Mary Beth Fritz
Senior Vice PresidentQuality & Regulatory Affairs
Adopted 10b5-1 plan Dec 2, 2024 10-Q Feb 6, 2025
What the company wrote
The following is a summary of the material terms of the contracts, instructions or written plans for the purchase or sale of the Company's securities adopted or terminated by our officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) or directors during the three months ended December 31, 2024: Name and Position Date Action Satisfies Affirmative Defense under Rule 10b5-(c) Expiration Date Total Ordinary Shares to be Sold Mary Beth Fritz December 2, 2024 Adoption X June 30, 2025 10,713 Senior Vice President Quality & Regulatory Affairs
Mary Beth Fritz
Senior Vice President
Adopted 10b5-1 plan Sep 15, 2023 10-Q Nov 2, 2023

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 5, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
May 11, 2026 Zerillo Jeffrey
Officer
351 $18K
May 7, 2026 Zerillo Jeffrey
Officer
305 $17K
May 6, 2026 Zerillo Jeffrey
Officer
1,207 $66K
May 5, 2026 Zerillo Jeffrey
Officer
346 $19K
Feb 11, 2026 Zerillo Jeffrey
Officer
1,000 $66K
Dec 1, 2025 Zerillo Jeffrey
Officer
281 $17K
Nov 28, 2025 Zerillo Jeffrey
Officer
719 $43K
Nov 25, 2025 BYOM JOHN E
Director
3,000 $178K

From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PBH/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.